comparemela.com

Latest Breaking News On - Epigenomics inc - Page 4 : comparemela.com

Global In-Vitro Colorectal Cancer Screening Tests Market Expected To Reach $ 1316 7 Million Growth By 2027||Epigenomics Inc, Hemosure, Inc, Exact Sciences Corporation, NOVIGENIX SA, Sekisui Diagnostics – KSU

33 In-vitro colorectal cancer screening tests market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to reach at USD 1316.7 million and at a growth rate CAGR of 6.40% in the above-mentioned forecast period. Introduction of novel screening tests employing genetic testing, growing incidence of rectal and colon cancer are some factors driving the growth of the market. The major players covered in the in-vitro colorectal cancer screening tests market report are  Abbott, Clinical Genomics Technologies Pty, Ltd, Epigenomics Inc, Hemosure, Inc, Exact Sciences Corporation, NOVIGENIX SA, Sekisui Diagnostics, Medline Industries, Inc, Beckman Coulter, Inc, Eiken Chemical Co, Ltd, Sysmex Corporation, Siemens Healthcare Private Limited, Quest Diagnostics Incorporated, Oncocyte, Merck KGaA, Immunostics Inc, ExiQon, Kyowa Electronic Instruments Co. Ltd, R-Biopharm AG among other domestic and global players

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.